$54.00

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI01750_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Adenine-9-b-D-arabinofuranoside
Brand Name
Chem Impex
Product Number
01750
CAS
5536-17-4
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
21704
IUPAC Name
(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI Key
OIRDTQYFTABQOQ-UHTZMRCNSA-N
SMILES
C1=NC(=C2C(=N1)N(C=N2)C@H3C@H(C@@H(C@H(O3)CO)O)O)N

Application

Adenine-9-b-D-arabinofuranoside is widely utilized in research focused on:

Antiviral Research: This compound is studied for its potential to inhibit viral replication, making it valuable in the development of antiviral therapies, particularly against retroviruses.

Gene Therapy: Its role as a nucleoside analog allows it to be incorporated into RNA, which can be beneficial in gene therapy applications where modification of genetic material is required.

Pharmaceutical Development: Used in the synthesis of various pharmaceutical agents, it helps in creating drugs that target specific biological pathways, enhancing therapeutic efficacy.

Biochemical Research: Researchers utilize it to study nucleic acid metabolism and cellular processes, providing insights into fundamental biological mechanisms.

Diagnostics: Its properties enable the development of diagnostic tools for detecting viral infections, contributing to faster and more accurate medical diagnostics.

References Data Source From Pubchem

Isoxazole derivatives as multi-target agents: virucidal, antibacterial, and antiproliferative effects on skin cancer cells

Publication Name: Pharmacological reports : PR
Publication Date: 2026-03-04
DOI: 10.1007/s43440-026-00839-5

Epidemiology of herpes zoster and postherpetic neuralgia in Japan: analysis of a large-scale claims database

Publication Name: BMC Infectious Diseases
Publication Date: 2026-01-10
DOI: 10.1186/s12879-026-12534-0

OSMAC strategy and LC–MS profiling reveal metabolic diversity and bioactivities of Xylaria thienhirunae SWUF17-44.1

Publication Name: Annals of Microbiology
Publication Date: 2026-01-05
DOI: 10.1186/s13213-025-01838-2

Antiviral Drug Design: Past, Presence, and Future

Publication Name: Advances in experimental medicine and biology
Publication Date: 2026
DOI: 10.1007/978-3-032-03402-1_37